Advertisement

MR Imaging in the Follow-Up Post Therapy

  • Paola D’Aprile
  • Alfredo Tarantino
Chapter

Abstract

Great advances have been made in the last years about the treatment of spondyloarthritis.

The aim of the treatment is to control signs and symptoms of the patient, to prevent joint damage, and to maintain the quality of life and functional ability.

MRI provides therapeutic guidance at any time during the course of the disease and it supplies objective information on the degree of inflammation and response to treatment.

References

  1. 1.
    Zochling J, Bohl-Buhler MM, Baraliakos X, et al. Non steroidal anti-inflammatory drug use in ankylosing spondylitis a population-based survey. Clin Rheumatol. 2006;25(6):794–800.CrossRefGoogle Scholar
  2. 2.
    Song IH, Haibel H, Poddubnyy D, et al. Withdrawal of biologic therapy in axial spondyloarthritis the experience in early disease. Clin Exp Rheumatol. 2013;31(Suppl 78):s37–42.PubMedGoogle Scholar
  3. 3.
    Baraliakos X, Davis J, Tsuji W, et al. MRI examinations of the spine in patient with ankylosing spondylitis before and after therapy with the TNF-alpha receptor fusion protein etanercept. Arthritis Rheum. 2005;52:1216–23.CrossRefGoogle Scholar
  4. 4.
    Rudwaleit M, baraliakos X, Listing J, et al. Magnetic resonance imaging of the spine and the sacroiliac joint in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept. Ann Rheum Dis. 2005;64:1305–10.CrossRefGoogle Scholar
  5. 5.
    Rudwaleit M, van der Heijde D, Khan MA, et al. How to diagnose axial spondyloarthritis early. Ann Rheum Dis. 2004;63:535–43.CrossRefGoogle Scholar
  6. 6.
    Sieper J, Rudwaleit M, Baraliakos X, et al. The Assessment of Spondyloarthritis International Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009;68(Suppl 2):1–44.CrossRefGoogle Scholar
  7. 7.
    Bollow M, Enzeweller C, Taupitz M, et al. Use of contrast enhanced magnetic resonance imaging to detect spinal inflammation in patients with spondyloarthritides. Clin Exp Rheumatol. 2002;20(Suppl 28):s167–74.PubMedGoogle Scholar
  8. 8.
    Canella C, Schau B, Ribeiros E, et al. MRI in seronegative spondyloarthritis: imaging features and differential diagnosis in the spine and sacroiliac joint. AJR Am J Roentgenol. 2013;200:149–57.CrossRefGoogle Scholar
  9. 9.
    Baraliakos X, Hermann K-GA, Landewe R, et al. Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: a comparison between contrast enhanced T1 and short tau inversion recovery (stir) sequences. Ann Rheum Dis. 2005;64:1141–4.CrossRefGoogle Scholar
  10. 10.
    Bennet AN, Rehman A, Hensor EM, et al. Evaluation of the diagnostic utility of spinal magnetic resonance imaging in axial spondyloarthritis. Arthritis Rheum. 2009;60:1331–41.CrossRefGoogle Scholar
  11. 11.
    Chary-valckenaere I, D’Agostino MA, Loeuille D. Role for imaging studies in ankylosing spondylitis. Joint Bone Spine. 2011;78:138–43.CrossRefGoogle Scholar

Suggested Readings

  1. Ciurea A, Scherer A, Exer P, et al. Tumor necrosis factor alpha inhibition in radiographic and non radiographic axial spondyloarthritis: result from a large observational cohort. Arthritis Rheum. 2013;65(12):3096–106.CrossRefGoogle Scholar
  2. Kısaarslan AP, Sözeri B, Gündüz Z, et al. Evaluation of factors affecting the duration of disease-modifying anti-rheumatic drugs application in patients with enthesitis-related arthritis. Eur J Rheumatol. 2019;22:1–5.Google Scholar
  3. Pedersen SJ, Weber U, Said-Nahal R, et al. Structural progression rate decreases over time on serial radiography and magnetic resonance imaging of sacroiliac joints and spine in a five-year follow-up study of patients with ankylosing spondylitis treated with tumour necrosis factor inhibitor. Scand J Rheumatol. 2019;48(3):185–97.CrossRefGoogle Scholar
  4. Rios Rodriguez V, Hermann KG, Weiß A, et al. Progression of structural damage in the sacroiliac joints in patients with early axial spondyloarthritis during long-term anti-tumor necrosis factor treatment: six-year results of continuous treatment with etanercept. Arthritis Rheumatol. 2019;71(5):722–8.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Paola D’Aprile
    • 1
  • Alfredo Tarantino
    • 1
  1. 1.Radiology - Neuroradiology SectionSan Paolo HospitalBariItaly

Personalised recommendations